Research
Christchurch mutation points to potential gene therapy avenue for Parkinson's
The Brief
- A rare genetic mutation may protect against developing Parkinson's disease and Lewy body dementia, according to a new study.
- The study comes from researchers at Oregon Health & Science University.
- The mutation, known as the Christchurch mutation, points to a potential gene therapy avenue for Parkinson's.
Why it matters
The findings point to a possible gene-therapy target for two neurodegenerative diseases, but the source describes a potential avenue rather than a proven treatment.
Who’s affected
- researchers studying Parkinson's disease and Lewy body dementia
- people at risk of or living with Parkinson's disease
- #parkinsons
- #lewy-body-dementia
- #gene-therapy
- #genetics
- #neurodegeneration
A rare genetic mutation may protect against developing Parkinson's disease and Lewy body dementia, a new study from researchers at Oregon Health & Science University suggests.